Self-restriction of medications due to cost in seniors without prescription coverage - A national survey

被引:197
作者
Steinman, MA
Sands, LP
Covinsky, KE
机构
[1] San Francisco VA Med Ctr, Div Geriatr, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] San Francisco VA Med Ctr, VA Natl Qual Scholars Program, San Francisco, CA 94121 USA
关键词
insurance; pharmaceutical services; health services accessibility; prescriptions; drug; fees; pharmaceutical; aged;
D O I
10.1046/j.1525-1497.2001.10412.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
OBJECTIVE: Little is known about patients who skip doses or otherwise avoid using their medications because of cost. We sought to identify which elderly patients are at highest risk of restricting their medications because of cost, and how prescription coverage modifies this risk. DESIGN AND PARTICIPANTS: Cross-sectional study from the 1995-1996 wave of the Survey of Asset and Health Dynamics Among the Oldest Old, a population-based survey of Americans age 70 years and older. MEASUREMENTS: Subjects were asked the extent of their prescription coverage, and whether they had taken less medicine than prescribed for them because of cost over the prior 2 years. We used bivariate and multivariate analyses to identify risk factors for medication restriction in subjects who lacked prescription coverage. Among these high-risk groups, we then examined the effect of prescription coverage on rates of medication restriction. MAIN RESULTS: Of 4,896 seniors who regularly used prescription medications, medication restriction because of cost was reported by 8% of subjects with no prescription coverage, 3% with partial coverage, and 2% with full coverage (P < .01 for trend). Among subjects with no prescription coverage, the strongest independent predictors of medication restriction were minority ethnicity (odds ratio [OR], 2.9 compared with white ethnicity; 95% confidence interval [95% CI], 2.0 to 4.2), annual income <$10,000 (OR, 3.8 compared with income greater than or equal to $20,000; 95% CI, 2.4 to 6.1), and out-of-pocket prescription drug costs >$100 per month (OR, 3.3 compared to costs less than or equal to $20; 95% CI, 1.5 to 7.2). The prevalence of medication restriction in members of these 3 risk groups was 21%, 16%, and 13%, respectively. Almost half (43%) of subjects with all 3 risk factors and no prescription coverage reported restricting their use of medications. After multivariable adjustment, highrisk subjects with no coverage had 3 to 15 times higher odds of medication restriction than subjects with partial or full coverage (P < .01). CONCLUSIONS: Medication restriction is common in seniors who lack prescription coverage, particularly among certain vulnerable groups. Seniors in these high-risk groups who have prescription coverage are much less likely to restrict their use of medications.
引用
收藏
页码:793 / 799
页数:7
相关论文
共 42 条
  • [1] Drug coverage and drug purchases by medicare beneficiaries with hypertension
    Blustein, J
    [J]. HEALTH AFFAIRS, 2000, 19 (02) : 219 - 230
  • [2] PATIENTS AS RELIABLE REPORTERS OF MEDICAL-CARE PROCESS - RECALL OF AMBULATORY ENCOUNTER EVENTS
    BROWN, JB
    ADAMS, ME
    [J]. MEDICAL CARE, 1992, 30 (05) : 400 - 411
  • [3] THE VALIDITY OF SELF-REPORTED PHYSICIAN UTILIZATION MEASURES
    CLEARY, PD
    JETTE, AM
    [J]. MEDICAL CARE, 1984, 22 (09) : 796 - 803
  • [4] RECALL BIAS IN EPIDEMIOLOGIC STUDIES
    COUGHLIN, SS
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1990, 43 (01) : 87 - 91
  • [5] *DEP HLTH HUM SERV, 2000, REP PRES PRESCR DRUG
  • [6] REPORT OF THE TASK-FORCE ON THE AVAILABILITY OF CARDIOVASCULAR DRUGS TO THE MEDICALLY INDIGENT
    DUSTAN, HP
    CAPLAN, LR
    CURRY, CL
    DELEON, AC
    DOUGLAS, FL
    FRISHMAN, W
    HILL, MN
    WASHINGTON, RL
    STEIGERWALT, S
    SHULMAN, NB
    TAUBERT, KA
    CHAMPAGNE, B
    GROOM, A
    [J]. CIRCULATION, 1992, 85 (02) : 849 - 860
  • [7] RACIAL-DIFFERENCES IN THE ELDERLY USE OF MEDICAL PROCEDURES AND DIAGNOSTIC-TESTS
    ESCARCE, JJ
    EPSTEIN, KR
    COLBY, DC
    SCHWARTZ, JS
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1993, 83 (07) : 948 - 954
  • [8] Patient self-reports in pharmacoeconomic studies - Their use and impact on study validity
    Evans, C
    Crawford, B
    [J]. PHARMACOECONOMICS, 1999, 15 (03) : 241 - 256
  • [9] The Republican and Democratic candidates speak on health care
    Gore, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (16) : 1184 - 1189
  • [10] Gross DJ, 1999, HEALTH SERV RES, V34, P241